Sun, Sep 21, 2014, 4:34 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Prana Biotechnology Limited Message Board

  • rt13101310 rt13101310 Jan 31, 2013 10:23 PM Flag

    Life Sciences Report January 31

    "Prana Biotechnology Ltd. (PBT:ASX) is taking on serious neurodegenerative diseases that disrupt the lives of patients and their families. The company has a miniscule $70M market cap, and shares should move dramatically on positive data. Results of phase 2b studies of the company’s orally bio-available PBT2 small molecule for the treatment of Huntington’s disease should be forthcoming in H2/13, and from an Alzheimer’s disease trial by the end of Q4/13. “This represents one of the biggest risk/reward opportunities of 2013,” says Senior Biotechnology Analyst George Zavoico of MLV & Co. “We are awaiting proof of concept and if it pans out, it should position Prana for a major partnership deal.”

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
PRAN
2.12-0.02(-0.93%)Sep 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.